Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
bullish
Enchem
Watchlist
TIGER Battery Material ETF Rebal in December: Notable Changes in Constituent Screening
Event-Driven
512 Views
11 Nov 2023 22:25
This post explores the latest screening outcomes of the TIGER Secondary Battery Materials ETF rebalancing in December, highlighting significant alterations in constituent selection.
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 3-minute read)
Related Insights
More »
Enchem Placement- Easily Digestible but a Punt at Best
Block Deal Sale of 3.6% Shares of Enchem
TIGER Battery Material ETF Rebal in December: Notable Changes in Constituent Screening
Enchem: Block Deal Sale of 14% of Outstanding Shares
KOSDAQ 150 Rebalancing: Complete List of Candidates, Including Enchem
Trending Collections
More »
Index Rebalance
Event-Driven
Equity Bottom-Up
Philippines
Podcasts
Japan
Unpaywalled Insights
South Korea
Equity Capital Markets (ECM)
Equity Derivatives
Trending Insights
More »
ESR Group (1821 HK): Precondition Satisfied
ESR (1821 HK): Pre-Cons Done. Scheme Doc By 22nd May
FXI Rebalance Preview: Pop Mart (9992 HK) Pops Up Again
[Japan Activism?] Toyota Group Equity Affiliate and Murakami Target Aichi Steel Does Large ToSTNeT-3
CATL (3750 HK): Powered by the PetroDollar. HK Offer Overview and Valuations.
Top Unpaywalled Insights
More »
New Horizon Aircraft Ltd (HOVR) - Targeting Regional Air Mobility Market, PT at US$2
Bitcoin, Buffett, and the Barbarians at the Gate | Ep. #020 - The New Barbarians Podcast
AQR DNA in a Digital World: Systematic Edge with Connor Farley - The New Barbarians Episode #019
Curator's Cut: "Bubble" Tea, Japan M&A 🍿and TSMC from Different Lenses
The Coming Global Trade Re-Ordering
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
TIGER Battery Material ETF Rebal in December: Notable Changes in Constituent Screening
11 Nov 2023
Overlooked by the Market: A Compelling Long Short Opportunity in Newly-Listed ETF Rebal in Korea
25 Aug 2023
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.3
x